{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:23:14Z","timestamp":1789183394281,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canrad.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:29:37Z","timestamp":1720916977000},"page":"323-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u2018Folfirinox\u2019 chemotherapy combined with contact x-ray brachytherapy 50 kVp and \u2018CAP50\u2019 chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study"],"prefix":"10.1016","volume":"28","author":[{"given":"D.","family":"Mitrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Barbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Pac\u00e9-Loscos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scouarnec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ben-Dhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mineur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"\u00c9vesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Durand-Labrunie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2024.02.003_bib0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery\u00a0\u2013\u00a0the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.canrad.2024.02.003_bib0085","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2024.02.003_bib0090","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial","volume":"5","author":"Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0100","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.2022.40.16_suppl.3512","article-title":"Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: the 3-year results of OPERA randomized trial (NCT02505750)","volume":"40","author":"G\u00e9rard","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0105","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/1097-0142(197508)36:2+<696::AID-CNCR2820360813>3.0.CO;2-X","article-title":"Intracavitary irradiation of early rectal cancer for cure. A series of 186 cases","volume":"36","author":"Papillon","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2024.02.003_bib0110","first-page":"561109","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?","author":"Habr-Gama","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2024.02.003_bib0115","doi-asserted-by":"crossref","first-page":"LBA3514","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA3514","article-title":"Curative chemoradiation for low rectal cancer: early clinical outcomes from a multicentre phase II trial","volume":"40","author":"Jensen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0120","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2022.40.16_suppl.3502","article-title":"STAR-TREC phase II: can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?","volume":"40","author":"Parkinson Bach","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0125","unstructured":"Laurent C, principal investigator. Optimisation of response for organ preservation in rectal cancer: neoadjuvant chemotherapy and radiochemotherapy vs. radiochemotherapy (GRECCAR12). [clinical trial] URL: https:\/\/clinicaltrials.gov\/study\/NCT02514278."},{"key":"10.1016\/j.canrad.2024.02.003_bib0130","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14153665","article-title":"Morpheus phase II-III study: a preplanned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2024.02.003_bib0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with folfirinox and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (Unicancer-Prodige 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0140","first-page":"92","article-title":"Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: the time\/dose factor influence","volume":"24","author":"B\u00e9n\u00e9z\u00e9ry","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2024.02.003_bib0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canrad.2021.11.002","article-title":"Rectal cancer radiotherapy","volume":"26","author":"Vendrely","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2024.02.003_bib0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-med-062915-021419","article-title":"Management of rectal cancer without radical resection","volume":"68","author":"Beets","year":"2017","journal-title":"Annu Rev Med"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321824000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T13:36:59Z","timestamp":1724938619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321824000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1278321824000908"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2024.02.003","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018Folfirinox\u2019 chemotherapy combined with contact x-ray brachytherapy 50kVp and \u2018CAP50\u2019 chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}